Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36 N.5, and our video podcast, CANCER BUZZ TV.

ACORI Summit



Activating Equity in Community Oncology Research

The Association of Community Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.

The Summit's interactive discussions focused around:

  • The importance of expanding access to clinical trials for patients of all background—to ensure the highest quality care
  • Strategies for engaging patients and their caregivers in shared decision-making around trial enrollment
  • Case studies to demonstrate solutions for optimizing accrual and overcoming barriers to trial participation
  • Tools and resources to support care teams, including budget forms, IRB templates, etc.
  • How to incorporate the patient perspective into trial design: insights for trial sponsors   

We look forward to continuing these conversations and taking action that will tie directly into ACORI's three domains of equity, capacity building, and research diffusion. 

Stay tuned for an executive summary that will speak on themes of usability, feasibility, and degree of potential impact. If you have any additional ideas or feedback, please reach out directly to Janelle Schrag, MPH, Assistant Director of Research Programs.

Target Audience

Community oncology providers and researcher team members (all disciplines)

Patient advocates and advocacy organizations

Trial sponsors and industry

Research networks and cooperative groups

Government and regulatory agencies

Featured Faculty

Fashoyin-Aje-Lola-80x80Lola A. Fashoyin-Aje, MD, MPH
Associate Director, FDA Oncology Center of Excellence


Green-Sybil-80x80Sybil Green, JD, RPh, MHA
Diversity and Inclusion Officer, American Society of Clinical Oncology (ASCO)


Regnante-Jeanne-80x80Jeanne Regnante
Chief Health Equity and Diversity Officer, LUNGevity Foundation

In Collaboration With


Our Supporters

abbvie-200x80 amgen-200x80 astrazeneca-200x80 eisai-200x80 genentech-200x80 merck-200x80 sanofi-genzyme-200x80-long

This project is supported by AbbVie, Amgen, AstraZeneca, Eisai, Genentech, Merck and Sanofi.

Twitter Highlights

More from #ACORISummit